CMND Clearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 0.21 $ 0.01 (3.34 %)    

Thursday, 20-Nov-2025 15:07:32 EST
QQQ $ 589.98 $ -21.69 (-3.55 %)
DIA $ 460.13 $ -6.55 (-1.4 %)
SPY $ 656.46 $ -16.44 (-2.45 %)
TLT $ 89.19 $ 0.20 (0.22 %)
GLD $ 375.24 $ 0.06 (0.02 %)
$ 0.2025
$ 0.20
$ 0.21 x 100
$ 0.21 x 15
$ 0.20 - $ 0.22
$ 0.18 - $ 2.18
11,758,825
na
nm
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) (&...

 clearmind-launches-new-trial-for-non-hallucinogenic-drug-aiming-to-curb-alcohol-addiction

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 clearmind-medicine-data-from-first-group-of-phase-iiia-clinical-study-of-cmnd-100-shows-favorable-safety-profile-no-serious-adverse-events-for-treatment-of-alcohol-use-disorder

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech co...

Core News & Articles

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 clearmind-medicine-cmnd-stock-soars-thursday-whats-going-on

Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. Here's a look at what you need to know.

 clearmind-receives-final-approval-from-hadassah-medical-center-jerusalem-for-ongoing-phase-12a-clinical-trial-evaluating-cmnd-100-proprietary-meai-based-oral-drug-candidate-for-aud-treatment

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 clearmind-medicine-announces-cnipa-publication-of-patent-for-meai-compound-in-depression-treatment

The notice was received by the China National Intellectual Property AdministrationVancouver, Canada, Nov. 12, 2025 (GLOBE NEWSW...

 clearmind-medicine-completes-first-patient-cohort-in-phase-iiia-trial-of-meai-based-cmnd-100-for-alcohol-use-disorder

Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion...

 why-is-clearmind-stock-down-today

Shares of Clearmind Medicine Inc. (NASDAQ: CMND) are falling Friday after the clinical-stage biotech company shared a key updat...

 clearmind-medicine-receives-nasdaq-delisting-notification

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech co...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION